These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 75929)

  • 1. Leukocyte complement: neoantigens of the membrane attack complex on the surface of human leukocytes prepared from defibrinated blood.
    Sundsmo JS; Kolb WP; Müller-Eberhard HJ
    J Immunol; 1978 Mar; 120(3):850-4. PubMed ID: 75929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte complement: assembly of the membrane attack complex of complement by human peripheral blood leukocytes in the presence and absence of serum.
    Sundsmo JS; Curd JG; Kolb WP; Müller-Eberhard HJ
    J Immunol; 1978 Mar; 120(3):855-60. PubMed ID: 416143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoantigen of the complement membrane attack complex of cytotoxic human peripheral blood lymphocytes.
    Sundsmo JS; Müller-Eberhard HJ
    J Immunol; 1979 Jun; 122(6):2371-8. PubMed ID: 87461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoantigen of the membrane attack complex of human complement: Occurrence on peripheral blood leukocytes from patients with systemic lupus erythematosus.
    Curd JG; Sundsmo JS; Kolb WP; Bluestein HG; Müller-Eberhard HJ
    Arthritis Rheum; 1978 Mar; 21(2):177-82. PubMed ID: 76471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement lysis: evidence for an amphiphilic nature of the terminal membrane C5b-9 complex of human complement.
    Bhakdi S; Bjerrum OJ; Bhakdi-Lehnen B; Tranum-Jensen J
    J Immunol; 1978 Dec; 121(6):2526-32. PubMed ID: 569173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
    Hoover DL; Berger M; Hammer CH; Meltzer MS
    J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.
    Schäfer H; Mathey D; Hugo F; Bhakdi S
    J Immunol; 1986 Sep; 137(6):1945-9. PubMed ID: 3528291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA; Sims PJ
    J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes.
    Horwitz DA; Garrett MA
    J Immunol; 1977 May; 118(5):1712-21. PubMed ID: 140193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
    Müller-Eberhard HJ; Zalman LS; Chiu FJ; Jung G; Martin DE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():28-34. PubMed ID: 3612651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes.
    Xia P; Jordon RE; Geoghegan WD
    J Clin Invest; 1988 Dec; 82(6):1939-47. PubMed ID: 2461964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the membrane attack mechanism of complement.
    Kolb WP; Haxby JA; Arroyave CM; Müller-Eberhard HJ
    J Exp Med; 1972 Mar; 135(3):549-66. PubMed ID: 5058233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoantigens of the membrane attack complex of human complement.
    Kolb WP; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1975 May; 72(5):1687-9. PubMed ID: 51500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel.
    Bhakdi S; Tranum-Jensen J; Klump O
    J Immunol; 1980 May; 124(5):2451-7. PubMed ID: 6154104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL; Sodetz JM
    Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera.
    Williams RC; Hughes GR; Snaith ML; Parry HF; Diao E; Greaves MF
    J Clin Invest; 1980 Feb; 65(2):379-89. PubMed ID: 6153183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.